Eric founded Forepont in 2017 and serves as the managing partner of the Bio&Med Fund and the co-managing partner of the Brain AI Fund.

Investor and company builder with one of the most extensive investment track records in the field – including early investments before their inflection points in Synchron and Precision Neuroscience, among others. Built, bought, and sold successful companies, including a $4 billion AUM Nexar sold to UBP, and the acquisition of $3 billion Allianz Insurance’s AAAM and $1 billion Ermitage.

Previously managed a $10+ billion alternative investment company with awarded performance. Funded basic research in Neurology and Neuro-immunology at renowned hospitals, and developed a strong network, including top specialists in Brain AI.

PhD (ABD) and MPhil in Computer Science (Neural Networks), Bachelor in Engineering & Master in Business Administration.